124 related articles for article (PubMed ID: 34985580)
1. Does PAX7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance?
Machado I; Charville GW; Yoshida A; Navarro S; Righi A; Gambarotti M; Scotlandi K; López-Guerrero JA; Llombart-Bosch A
Virchows Arch; 2022 Apr; 480(4):909-917. PubMed ID: 34985580
[TBL] [Abstract][Full Text] [Related]
2. Correlation NKX2.2 IHC and
Pasricha S; Pahwa S; Pruthi M; Jajodia A; Gupta G; Sharma A; Durga G; Kamboj M; Tiwari A; Panigrahi M; Mehta A
Indian J Pathol Microbiol; 2023; 66(1):58-62. PubMed ID: 36656211
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors.
Machado I; Yoshida A; López-Guerrero JA; Nieto MG; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2017 Sep; 213(9):1048-1053. PubMed ID: 28864350
[TBL] [Abstract][Full Text] [Related]
4. The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma.
Shibuya R; Matsuyama A; Nakamoto M; Shiba E; Kasai T; Hisaoka M
Virchows Arch; 2014 Nov; 465(5):599-605. PubMed ID: 25031013
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors.
McCuiston A; Bishop JA
Head Neck Pathol; 2018 Mar; 12(1):89-94. PubMed ID: 28616785
[TBL] [Abstract][Full Text] [Related]
6. NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.
Yoshida A; Sekine S; Tsuta K; Fukayama M; Furuta K; Tsuda H
Am J Surg Pathol; 2012 Jul; 36(7):993-9. PubMed ID: 22446943
[TBL] [Abstract][Full Text] [Related]
7. CD99 and NKX2.2 positive neuroblastoma diagnosed on cytology: A potential diagnostic pitfall and necessity of pathological evaluation of the primary site.
Aparna Devi C; Alashetty S; Champaka G; Dharmalingam P; Kapali A; Kumar N
Diagn Cytopathol; 2023 Jun; 51(6):E189-E194. PubMed ID: 36999306
[TBL] [Abstract][Full Text] [Related]
8. PAX7 immunohistochemical evaluation of Ewing sarcoma and other small round cell tumours.
Toki S; Wakai S; Sekimizu M; Mori T; Ichikawa H; Kawai A; Yoshida A
Histopathology; 2018 Oct; 73(4):645-652. PubMed ID: 29920735
[TBL] [Abstract][Full Text] [Related]
9. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
[TBL] [Abstract][Full Text] [Related]
10. NKX2.2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: Diagnostic utility and pitfalls.
Russell-Goldman E; Hornick JL; Qian X; Jo VY
Cancer Cytopathol; 2018 Nov; 126(11):942-949. PubMed ID: 30376220
[TBL] [Abstract][Full Text] [Related]
11. Expression of NKX2.2 in Non-Ewing Tumors With Round Cell Morphology.
Saeed SM; Hassan U; Hussain M; Mushtaq S; Ishtiaq S
Cureus; 2023 Dec; 15(12):e50704. PubMed ID: 38234938
[TBL] [Abstract][Full Text] [Related]
12. Meningeal Ewing Sarcoma/Peripheral PNET: Clinicopathological, Immunohistochemical and FISH study of four cases.
Ke Ch; Duan Q; Yang H; Zhu F; Yan M; Xu SP; Zhou S; Wan F; Shu K; Lei T; Xia LM
Neuropathology; 2017 Feb; 37(1):35-44. PubMed ID: 27500883
[TBL] [Abstract][Full Text] [Related]
13. Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities.
Specht K; Sung YS; Zhang L; Richter GH; Fletcher CD; Antonescu CR
Genes Chromosomes Cancer; 2014 Jul; 53(7):622-33. PubMed ID: 24723486
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of NKX2.2, a target of EWSR1/FLI1 fusion transcript, in primary renal Ewing sarcoma.
Yamamoto Y; Yamazaki K; Ishida Y
J Cytol; 2015; 32(1):30-2. PubMed ID: 25948942
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.
Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW
Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787
[TBL] [Abstract][Full Text] [Related]
16. Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support.
Llombart-Bosch A; Machado I; Navarro S; Bertoni F; Bacchini P; Alberghini M; Karzeladze A; Savelov N; Petrov S; Alvarado-Cabrero I; Mihaila D; Terrier P; Lopez-Guerrero JA; Picci P
Virchows Arch; 2009 Nov; 455(5):397-411. PubMed ID: 19841938
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry for PAX7 is a useful confirmatory marker for Ewing sarcoma in decalcified bone marrow core biopsy specimens.
Fernandez-Pol S; van de Rijn M; Natkunam Y; Charville GW
Virchows Arch; 2018 Dec; 473(6):765-769. PubMed ID: 30014288
[TBL] [Abstract][Full Text] [Related]
18. Identification of a New Transcriptional Co-Regulator of STEAP1 in Ewing's Sarcoma.
Markey FB; Romero B; Parashar V; Batish M
Cells; 2021 May; 10(6):. PubMed ID: 34073779
[TBL] [Abstract][Full Text] [Related]
19. Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases.
Jimenez RE; Folpe AL; Lapham RL; Ro JY; O'Shea PA; Weiss SW; Amin MB
Am J Surg Pathol; 2002 Mar; 26(3):320-7. PubMed ID: 11859203
[TBL] [Abstract][Full Text] [Related]
20. EWSR1-NFATC2 Translocation-associated Sarcoma Clinicopathologic Findings in a Rare Aggressive Primary Bone or Soft Tissue Tumor.
Wang GY; Thomas DG; Davis JL; Ng T; Patel RM; Harms PW; Betz BL; Schuetze SM; McHugh JB; Horvai AE; Cho SJ; Lucas DR
Am J Surg Pathol; 2019 Aug; 43(8):1112-1122. PubMed ID: 30994538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]